Acute respiratory infection is a significant cause of illness and death in young, geriatric and immunocompromised patients. Co-infection with multiple organisms is also common within these patient populations. Access to advanced technology is essential to detect multiple pathogens at once. VolenteDx is proud to offer our best-in-industry Respi Dx™ diagnostic panel. Utilizing the best in technology, Respi Dx™ reduces false negative test results that can lead to a delayed diagnosis and poor clinical outcomes. Respi Dx™ quickly identifies all organisms and pathogens in the respiratory tract and with our powerful Antibiotic Resistance Dx™ panel, VolenteDx detects potential bacterial antibiotic resistance, so effective supportive care and antibiotic treatment can begin as early as possible. Additionally, the combination of Respi Dx™ and Antibiotic Resistance Dx™ can help physicians and facilities to strengthen antibiotic stewardship programs. VolenteDx brings together valuable tools for the best in respiratory diagnostics, avoidance of adverse events and prevention of unnecessary antibiotic prescribing.